Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Kiniksa Pharmaceuticals International (KNSA) Gross Profit (2021 - 2026)

Kiniksa Pharmaceuticals International filings provide 6 years of Gross Profit readings, the most recent being $193.5 million for Q1 2026.

  • On a quarterly basis, Gross Profit rose 61.34% to $193.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $673.4 million, a 63.07% increase, with the full-year FY2025 number at $599.9 million, up 65.57% from a year prior.
  • Gross Profit hit $193.5 million in Q1 2026 for Kiniksa Pharmaceuticals International, up from $181.2 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $193.5 million in Q1 2026 to a low of -$155.0 million in Q4 2022.
  • Median Gross Profit over the past 5 years was $92.1 million (2024), compared with a mean of $81.5 million.
  • The widest YoY moves for Gross Profit: up 888.4% in 2022, down 769.77% in 2022.
  • Kiniksa Pharmaceuticals International's Gross Profit stood at -$155.0 million in 2022, then soared by 147.62% to $73.8 million in 2023, then skyrocketed by 41.77% to $104.6 million in 2024, then surged by 73.15% to $181.2 million in 2025, then increased by 6.78% to $193.5 million in 2026.
  • The last three reported values for Gross Profit were $193.5 million (Q1 2026), $181.2 million (Q4 2025), and $160.6 million (Q3 2025) per Business Quant data.